{"id":"https://openalex.org/W4310112786","doi":"https://doi.org/10.1182/blood-2022-167175","title":"Impact of Exercise on the Complications of Corticosteroids in Patients with Graft-Versus-Host Disease Following Allogeneic Cell Transplantation: The Restart Trial","display_name":"Impact of Exercise on the Complications of Corticosteroids in Patients with Graft-Versus-Host Disease Following Allogeneic Cell Transplantation: The Restart Trial","publication_year":2022,"publication_date":"2022-11-15","ids":{"openalex":"https://openalex.org/W4310112786","doi":"https://doi.org/10.1182/blood-2022-167175"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2022-167175","doi":"https://doi.org/10.1182/blood-2022-167175","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-167175","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5058778398","display_name":"Rebekah L. Wilson","orcid":"https://orcid.org/0000-0003-1704-3624","observed_orcids":["https://orcid.org/0000-0003-1704-3624"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Rebekah L. Wilson","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040573037","display_name":"Dong\u2010Woo Kang","orcid":"https://orcid.org/0000-0003-2292-1946","observed_orcids":["https://orcid.org/0000-0003-2292-1946"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Dong-Woo Kang","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011606738","display_name":"Paola Gonzalo Encabo","orcid":"https://orcid.org/0000-0001-5793-1437","observed_orcids":["https://orcid.org/0000-0001-5793-1437"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paola Gonzalo-Encabo","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042227976","display_name":"Cami N. Christopher","orcid":"https://orcid.org/0000-0002-7238-0546","observed_orcids":["https://orcid.org/0000-0002-7238-0546"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Cami Christopher","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004436879","display_name":"Amber J. Normann","orcid":"https://orcid.org/0000-0002-2397-7063","observed_orcids":["https://orcid.org/0000-0002-2397-7063"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Amber Normann","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054401801","display_name":"Danny Nguyen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Danny Nguyen","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086744800","display_name":"Mary K. Norris","orcid":"https://orcid.org/0000-0002-8914-1306","observed_orcids":["https://orcid.org/0000-0002-8914-1306"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mary K. Norris","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5070876018","display_name":"Marilyn J. Hammer","orcid":"https://orcid.org/0000-0002-9561-6144","observed_orcids":["https://orcid.org/0000-0002-9561-6144"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marilyn J. Hammer","raw_affiliation_strings":["2Dana-Farber Cancer Institute, Boston,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Dana-Farber Cancer Institute, Boston,","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029278364","display_name":"Corey S. Cutler","orcid":"https://orcid.org/0000-0001-8728-4314","observed_orcids":["https://orcid.org/0000-0001-8728-4314"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Corey Cutler","raw_affiliation_strings":["3Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Inst., Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Division of Stem Cell Transplantation and Cellular Therapy, Dana-Farber Cancer Inst., Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5040836604","display_name":"Christina Marie Dieli-Conwright","orcid":"https://orcid.org/0000-0001-9093-7259","observed_orcids":["https://orcid.org/0000-0001-9093-7259"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Christina M. Dieli-Conwright","raw_affiliation_strings":["1Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210117453"],"apc_list":{"value":2500,"currency":"USD","value_usd":2500},"apc_paid":null,"fwci":0.1823,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.53077873,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":94},"biblio":{"volume":"140","issue":"Supplement 1","first_page":"4782","last_page":"4783"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10345","display_name":"Hematopoietic Stem Cell Transplantation","score":0.9214000105857849,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10178","display_name":"Cancer survivorship and care","score":0.035100001841783524,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10352","display_name":"Physical Activity and Health","score":0.01940000057220459,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/graft-versus-host-disease","display_name":"graft-versus-host disease","score":0.9810000061988831},{"id":"https://openalex.org/keywords/corticosteroid-side-effects","display_name":"corticosteroid adverse effects","score":0.8560000061988831},{"id":"https://openalex.org/keywords/exercise-intervention","display_name":"exercise intervention","score":0.9100000262260437},{"id":"https://openalex.org/keywords/allogeneic-hematopoietic-stem-cell-transplantation","display_name":"allogeneic hematopoietic stem cell transplantation","score":0.9300000071525574},{"id":"https://openalex.org/keywords/aerobic-exercise","display_name":"aerobic exercise","score":0.8759999871253967},{"id":"https://openalex.org/keywords/resistance-training","display_name":"resistance training","score":0.8539999723434448},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.8730000257492065},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.35100001096725464},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.6399999856948853},{"id":"https://openalex.org/keywords/fasting-blood-glucose","display_name":"fasting blood glucose","score":0.3880000114440918},{"id":"https://openalex.org/keywords/body-composition","display_name":"body composition","score":0.3190000057220459},{"id":"https://openalex.org/keywords/body-fat","display_name":"fat mass","score":0.3930000066757202},{"id":"https://openalex.org/keywords/muscle-mass","display_name":"muscle mass","score":0.7059999704360962},{"id":"https://openalex.org/keywords/bone-mineral-density","display_name":"bone mineral density","score":0.7940000295639038},{"id":"https://openalex.org/keywords/bone-loss","display_name":"bone loss","score":0.45100000500679016},{"id":"https://openalex.org/keywords/bone-turnover-markers","display_name":"bone turnover markers","score":0.382999986410141}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9273563623428345},{"id":"https://openalex.org/C2911091166","wikidata":"https://www.wikidata.org/wiki/Q106419912","display_name":"Transplantation","level":2,"score":0.5842989683151245},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.5361214876174927},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.4972260296344757},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.49274685978889465},{"id":"https://openalex.org/C2777408962","wikidata":"https://www.wikidata.org/wiki/Q1128050","display_name":"Hematopoietic stem cell transplantation","level":3,"score":0.4604935944080353},{"id":"https://openalex.org/C103038586","wikidata":"https://www.wikidata.org/wiki/Q1152037","display_name":"Aerobic exercise","level":2,"score":0.44229796528816223},{"id":"https://openalex.org/C2779972918","wikidata":"https://www.wikidata.org/wiki/Q1194520","display_name":"Graft-versus-host disease","level":3,"score":0.4421869218349457},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.43527668714523315},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.4132065773010254},{"id":"https://openalex.org/C1862650","wikidata":"https://www.wikidata.org/wiki/Q186005","display_name":"Physical therapy","level":1,"score":0.38394421339035034},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.35798344016075134},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood-2022-167175","doi":"https://doi.org/10.1182/blood-2022-167175","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood-2022-167175","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2253631719","https://openalex.org/W2072073756","https://openalex.org/W2041993316","https://openalex.org/W2132014173","https://openalex.org/W4224224068","https://openalex.org/W2117373932","https://openalex.org/W2056739864","https://openalex.org/W1912907767","https://openalex.org/W7000207497","https://openalex.org/W2896312322"],"abstract_inverted_index":{"Background:":[0],"Graft-Versus-Host":[1],"Disease":[2],"(GVHD)":[3],"is":[4,51,122,313,371,379,412,424,440,462,473],"a":[5,52,92,137,190,303,385,418,550],"common":[6,59],"but":[7],"burdensome":[8],"side":[9,60,74],"effect":[10],"of":[11,20,25,91,184,203,289,310,355,358,397,489,495,516,552],"allogeneic":[12,102,162],"hematopoietic":[13],"cell":[14],"transplant":[15],"(HCT)":[16],"occurring":[17],"in":[18,78,101,176,213,361,427,501],"35-50%":[19],"recipients.":[21],"Corticosteroids":[22],"are":[23,127,141,145,157,529],"standard":[24,551],"care":[26,553],"for":[27,192,249,266,279,286,442,513,521,535],"newly":[28,149],"diagnosed":[29,150,525],"GVHD;":[30],"however,":[31],"long-term":[32],"use":[33],"incurs":[34],"multiple":[35],"metabolic":[36],"abnormalities":[37],"including":[38,220,269],"hypertension,":[39,227],"atrial":[40],"fibrillation,":[41],"hyperglycemia,":[42],"fat":[43],"gain,":[44],"muscle":[45],"and":[46,97,111,173,243,282,321,340,348,394,448,472,486,518,545],"bone":[47],"loss.":[48],"While":[49],"exercise":[50,77,99,131,254,272,284,318,326,496,548],"viable":[53],"non-pharmacologic":[54],"intervention":[55,100,263,364],"that":[56,210,368],"can":[57],"mitigate":[58],"effects":[61,75,494],"associated":[62],"with":[63,76,105,151,294,523,526],"corticosteroids,":[64,160,531],"no":[65],"study":[66,312,461,482],"to":[67,71,129,181,245,247,323,406,541],"date":[68],"has":[69],"aimed":[70],"alleviate":[72],"corticosteroid-induced":[73],"the":[79,83,89,196,201,258,311,346,356,362,369,376,381,395,398,409,414,443,465,493,510,514,533,543],"GVHD":[80,106,155,527],"population.":[81],"Therefore,":[82],"RESTART":[84],"Trial":[85],"will":[86,256,301,344,391,402,430,450,508],"primarily":[87],"examine":[88],"feasibility":[90,314,357,389,422,515],"12-week,":[93],"virtually":[94,259],"supervised,":[95],"aerobic":[96,517],"resistance":[98,283,519],"HCT":[103,163,490],"recipients":[104],"receiving":[107,530],"corticosteroids.":[108],"Study":[109],"Design":[110],"Methods:":[112],"This":[113,460,480],"ongoing":[114,221,231],"two-arm,":[115],"single":[116],"center,":[117],"pilot":[118,511],"randomized":[119,128],"controlled":[120],"trial":[121],"recruiting":[123],"36":[124],"patients":[125,491,522],"who":[126,156,528],"an":[130,484],"or":[132,153,179,207,222,228,234,238,373,387,420,437,456],"attention":[133,298],"control":[134,299],"group":[135,255,300],"at":[136,168,200,274,292,469,475],"2:1":[138],"ratio.":[139],"Patients":[140],"eligible":[142],"if":[143],"they":[144],">18":[146],"years":[147],"old,":[148],"acute":[152],"chronic":[154],"prescribed":[158,325],"systemic":[159],"received":[161],"(any":[164],"conditioning,":[165],"any":[166,217],"donor)":[167],"Dana-Farber":[169],"Cancer":[170],"Institute":[171],"(DFCI),":[172],"currently":[174],"participate":[175],"less":[177],"than":[178],"equal":[180],"60":[182],"minutes":[183,281],"structured":[185],"exercise/week.":[186],"Exclusion":[187],"criteria":[188],"include":[189,333],"plan":[191],"hospital":[193],"admission":[194],"within":[195],"next":[197],"13":[198],"weeks":[199],"time":[202],"recruitment,":[204],"concurrent":[205,235],"musculoskeletal":[206],"cardiorespiratory":[208],"conditions":[209],"prevent":[211],"participation":[212],"moderate-vigorous":[214],"intensity":[215],"exercise,":[216],"uncontrolled":[218,225],"illness":[219],"active":[223,241,363],"infection,":[224],"diabetes,":[226],"thyroid":[229],"disease,":[230],"investigational":[232],"agents,":[233],"biological,":[236],"chemotherapy,":[237],"radiation":[239],"therapy,":[240],"malignancy,":[242],"inability":[244],"travel":[246],"DFCI":[248,470],"necessary":[250],"data":[251],"collection.":[252],"The":[253,297,307,330],"receive":[257,302],"(e.g.,":[260],"Zoom)":[261],"supervised":[262],"thrice":[264],"weekly":[265],"12":[267],"weeks,":[268],"aerobic-based":[270],"cycling":[271],"performed":[273,285],"50-75%":[275],"heart":[276],"rate":[277,390,423],"maximum":[278],"20-30":[280],"3":[287],"sets":[288],"10-12":[290],"repetitions":[291],"40-65%":[293],"1-repetition":[295],"maximum.":[296],"12-week":[304],"stretching":[305],"program.":[306],"primary":[308],"outcome":[309],"as":[315,439,549],"measured":[316],"by":[317,433,464],"session":[319],"attendance":[320],"ability":[322],"complete":[324],"(minutes":[327],"per":[328],"session).":[329],"secondary":[331,428],"outcomes":[332],"glycemic":[334],"control,":[335],"body":[336],"composition,":[337],"physical":[338],"function,":[339],"patient-reported":[341],"outcomes.":[342],"We":[343,366],"estimate":[345],"proportion":[347,370,378,411],"corresponding":[349],"95%":[350,400],"exact":[351,399],"confidence":[352],"interval":[353],"(CI)":[354],"our":[359,506],"program":[360],"group.":[365],"expect":[367],"70%":[372,386,419],"higher.":[374],"If":[375,408,504],"true":[377,410],"70%,":[380],"probability":[382,415],"we":[383,416],"observe":[384,417],"higher":[388,421],"be":[392,403,431,451],"60.8%,":[393],"length":[396],"CI":[401],"roughly":[404],"40%":[405],"44%.":[407],"75%,":[413],"78.6%.":[425],"Changes":[426],"endpoints":[429],"estimated":[432],"differences,":[434],"percent":[435],"change,":[436],"fold-change,":[438],"customary":[441],"endpoint.":[444],"Differences":[445],"between":[446],"post-":[447],"pre-intervention":[449],"assessed":[452],"using":[453],"paired":[454],"t-test":[455],"Wilcoxon":[457],"signed-rank":[458],"test.":[459],"approved":[463],"institutional":[466],"review":[467],"board":[468],"(#21-618)":[471],"registered":[474],"Clinical":[476],"Trials.gov":[477],"(NCT05236062).":[478],"Discussion:":[479],"first-of-its-kind":[481],"targets":[483],"understudied":[485],"vulnerable":[487],"population":[488],"where":[492],"have":[497],"only":[498],"been":[499],"examined":[500],"pre-clinical":[502],"settings.":[503],"positive,":[505],"findings":[507,544],"establish":[509,547],"efficacy":[512],"exercises":[520],"cancer":[524],"providing":[532],"foundation":[534],"future":[536],"larger":[537],"phase":[538],"II/III":[539],"trials":[540],"confirm":[542],"potentially":[546],"rehabilitation":[554],"service.":[555]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-09-29T14:09:16.559479","created_date":"2022-11-30T00:00:00"}